Vidac Pharma - Publications

News & Events

Max Herzberg: A case study in cancer research
Protein mislocation in cancer

ARTICLES

A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic Keratoses.

Behar V., Pahima H., Kozminsky-Atias A., Arbel N., Loeb E., Herzberg M. and Becker O. M., Journal of Investigative Dermatology (2018), 138(12):2635-2643.

POSTERS

SITC 2018:

Modulating Hexokinase 2 (HK2) as a Novel Approach for Simultaneous Targeting of the Tumor and Its Immunosuppressive Microenvironment

Fall Clinical Dermatology Conference ® 2018

A Novel Well-Tolerated Treatment for Actinic Keratosis.

AACR 2018:

Activating the NLRP3 Inflammasome in Macrophages and Triggering Apoptosis in Cancer Cells via HK2/VDAC Modulator.

LiveSites | Login

To Top